United States: In Limine Gag Orders – Can We Play, Too?

Last Updated: June 28 2016
Article by James Beck

Lately, we've seen some plaintiffs add gag order requests to their complement of in limine motions in advance of significant trials. Those of us who participated in the Bone Screw litigation remember plaintiffs attempting – and failing − to prevent the defendants from communicating with their customers (implanting physicians) about that litigation.  Unfortunately, no order resulted.  The first gag order relating to advertising involving civil litigation was entered at about the same time as our Bone Screw brouhaha in a securities-related case. Koch v. Koch Industries, Inc., 2 F. Supp.2d 1409 (D. Kan. 1998).  The court gagged both sides equally, and only after both sides agreed.  Id. at 1415 ("plaintiffs also ask the court to enter an order prohibiting the defendants from advertising" [and] "defendants apparently agree that the court should preclude both sides . . . from advertising").

Advertisements published or to be published by the parties in this case, whether selling products or ostensibly serving the public interest, seemingly carry messages directed at swaying public sentiment to that party's side in this case. In short, this case will tried in the courthouse; any attempt to try this matter in the media ends now.  In reaching this decision, the court has considered less restrictive means of preventing unfair prejudice attributable to pretrial publicity.  Unfortunately, the court can devise no content-based restriction that will be fairly and equally applied to the parties.  In light of the parties' respective requests for restraint, a total ban on advertising is not only simple and expedient, but seems most equitable.

Id. See also Pfahler v. Swimm, 2008 WL 323244, at *2 (D. Colo. Feb. 4, 2008) (rejecting plaintiffs' request for civil gag order).  Moreover, no matter what the parties might have been trying to communicate to potential jurors in Koch (there had also been a rather questionable opinion "poll" taken by one of the parties), we're sure that they weren't discussions of life saving medical products – or even corporate feel-good advertising of the sort seen while watching "Meet the Press" and other similar Sunday talk shows.

In prescription medical product liability litigation, such distinctions so far haven't mattered much. The First Amendment implications of gag orders against pre-trial advertising have been obvious to courts.  In In re Yasmin & Yaz (Drospirenone) Marketing, Sales Practices & Products Liability Litigation, 2011 WL 6740391 (S.D. Ill. Dec. 22, 2011), the plaintiffs moved in limine to prohibit the defendant from "initiating new advertising and marketing campaigns related to it being a good company that makes life-saving medicines" in the location of the trial or "or generating pretrial publicity before jury selection and during the trial in this case."  Id. at *19.  The motion was denied, largely on First Amendment grounds:

The Court finds that [defendant] denies any intent to engage in such pretrial publicity and plaintiff cannot direct the Court to any specific examples of offending advertising.  Further, prior restraint of First Amendment rights is very serious.  The Court would have to view the content of specific advertising prior to granting an order prohibiting it.

Id. The First Amendment also precluded a similar request in in In re Tylenol (Acetaminophen) Marketing, Sales Practices & Products Liability Litigation, 2016 WL 3125428 (E.D. Pa. June 3, 2016):

The plaintiff's request is somewhat unprecedented − to ask a civil defendant to restrain from engaging in certain marketing tactics pre-trial. . . . Pretrial publicity could affect the fairness of a civil trial by tainting the jury pool and process.  A prior restraint is one of the most extraordinary remedies known to our jurisprudence.  Prior restraints on speech and publication are the most serious and the least tolerable infringement on First Amendment rights. . . .  There is no reason to impose restraints on the defendants' speech rights at this time.  The defendants claim they do not plan to engage in pretrial advertising or publicity to bolster their reputation. . . .  [T]he extent and nature of the unfair publicity the plaintiff wishes to have restrained is vague and unclear.  Though the plaintiff claims her request is narrowly tailored because it limits the plaintiff to "the time preceding and during trials" and "in the limited market," these limitations are not well-defined.  They also could impose an undue burden on the defendants' speech rights when other means are available to mitigate juror bias.

Id. at *3 (citations, including to Koch, omitted).  Other product liability decisions rejecting similar plaintiff-side requests are: In re Prempro Products Liability Litigation (Hill), 2007 WL 3217470, at *4 (E.D. Ark. Oct. 26, 2007); In re Prempro Products Liability Litigation (Scroggin), 2007 WL 3125106, at *4 (E.D. Ark. Oct. 24, 2007); In re Prempro Products Liability Litigation (Rush), 2006 WL 3806391, at *2 (E.D. Ark. Dec. 27, 2006).  Diet Drug plaintiffs also tried this same tactic elsewhere, to no avail.

Then there is the interesting, and apparently agreed-upon, order entered concerning "communication with the media" in Norplant litigation.  Both sides agreed not to talk to the press, subject to two exceptions:

(3) Subject to the provisions of paragraph 5 [relating to abuse], this order does not prohibit counsel for plaintiffs from advertising their services to women who have used the Norplant System.

(4) Subject to the provisions of paragraph 5 [same], this order does not prohibit defendants from advertising the Norplant System and engaging in communications appropriate to the continued sale of the product, including, for example, responding to inquiries about the product from health care providers, scientists, researchers, government agencies, regulatory authorities, past, present and prospective users, and the media (regarding the product only, not the litigation).

In re Norplant Contraceptive Products Liability Litigation, 1996 WL 675561, at *1 (E.D. Tex. Nov. 14, 1996).

The Norplant order is particularly prescient in this context, in that it brings up the subject of plaintiff-side lawyer advertising.  The prejudicial effect of such advertising has itself been recognized. See Janssen Pharmaceutica, Inc. v. Bailey, 878 So. 2d 31, 51 (Miss. 2004) (change of venue appropriate where potential jurors had been "bombarded with attorney advertisements, attorney-organized meetings and plaintiff-propelled gossip").  To the extent that plaintiffs seek in limine orders precluding defendants from engaging in advertising defending their products, defendants would be well-justified in countering with similar requests to shut down plaintiff-side advertising concerning the same products, in the same geographic area, for the same time period.  Such solicitation is far more pernicious than anything a defendant would do.  Often such ads are falsely mimic newscasts.  Many disguise their source, containing the names of dummy firms that don't even  litigate.  Because the other side is not subject to FDA "balance" requirements, they routinely make overblown risk claims that never could stand up to FDA scrutiny.  Anything plaintiffs could possibly claim in support of an in limine gag order, they are already doing far worse.  If they want to play the silence-your-opponent game. a cross motion would certainly be in order.  In active litigation centers, the frequency of trials could result in overlapping gag orders shutting down this type of solicitation for extended periods.  What's sauce for the goose....

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

James Beck
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.